Sample size and power estimation for studies with health related quality of life outcomes: A comparison of four methods using the SF-36

Health and Quality of Life Outcomes

Volumn 2, Issue , 2004, Pages

  Walters, Stephen J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADOLESCENT; ADULT; ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; DATA BASE; EMPIRICISM; EXPERIMENTAL DESIGN; FEMALE; HEALTH STATISTICS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONBIOLOGICAL MODEL; NONPARAMETRIC TEST; NORMAL DISTRIBUTION; OUTCOMES RESEARCH; PILOT STUDY; QUALITY OF LIFE; RELIABILITY; SAMPLE SIZE; SCORING SYSTEM; STANDARDIZATION; STATISTICAL DISTRIBUTION; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING; ALGORITHM; HEALTH AUXILIARY; INSTRUMENTATION; METHODOLOGY; MIDWIFE; OUTCOME ASSESSMENT; POSTNATAL CARE; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; RISK; SICKNESS IMPACT PROFILE; SOCIAL SUPPORT; STATISTICAL ANALYSIS; STATISTICS;

ALGORITHMS; COMMUNITY HEALTH WORKERS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MIDWIFERY; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); POSTNATAL CARE; PSYCHOMETRICS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SAMPLE SIZE; SICKNESS IMPACT PROFILE; SOCIAL SUPPORT;

EID: 4243185841     PISSN: 14777525     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7525-2-26     Document Type: Article

References (36)

1. Altman DG, Machin D, Bryant TN, Gardner MJ: Statistics with Confidence: Confidence intervals and statistical guidelines 2nd edition. London: British Medical Journal; 2000.
2. Machin D, Campbell MJ, Fayers PM, Pinol APY: Sample Sizes Tables for Clinical Studies 2nd edition. Oxford: Blackwell Science; 1997.
3. Fayers PM, Machin D: Quality of Life Assessment, Analysis and Interpretation Chichester: Wiley; 2000.
4. Walters SJ, Campbell MJ, Lall R: Design and Analysis of Trials with Quality of Life as an Outcome: a practical guide. Journal of Biopharmaceutical Statistics 2001, 11(3):155-176.
5. Walters SJ, Campbell MJ, Paisley S: Methods for determining sample sizes for studies involving health-related quality of life measures: a tutorial. Health Services & Outcomes Research Methodology 2001, 2:83-99.
6. Efron B, Tibshirani RJ: An Introduction to the Bootstrap New York: Chapman & Hall; 1993.
7. Morrell CJ, Spiby H, Stewart P, Walters S, Morgan A: Costs and effectiveness of community postnatal support workers: randomised controlled trial. British Medical Journal 2000, 321:593-598.
8. Staquet MJ, Hays RD, Fayers PM: Quality of Life Assessment in Clinical Trials: Methods and Practice Oxford: Oxford University Press; 1998.
9. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992, 30:473-483.
10. Brazier JE, Harper R, Jones NMB, O'Cathain A, Thomas KJ, Usherwood T, Westlake L: Validating the SF-36 health survey questionnaire: new outcome measure for primary care. British Medical Journal 1992, 305:160-164.
11. Pocock SJ: Clinical Trials: A Practical Approach Chichester: Wiley; 1983.
12. Lehman EL: Nonparametric Statistical Methods Based on Ranks San Francisco: Holden-Day; 1975.
13. Noether GE: Sample Size Determination for Some Common Nonparametric Tests. J American Statistical Association 1987, 82(398):645-647.
14. Hamilton MA, Collings BJ: Determining the Appropriate Sample Size for Nonparametric Tests for Location Shift. Technometrics 1991, 3(33):327-337.
15. Simonoff JS, Hochberg Y, Reiser B: Alternative Estimation Procedures for Pr(X < Y) in Categorised Data. Biometrics 1986, 42:895-907.
16. Whitehead J: Sample size calculations for ordered categorical data. Statistics in Medicine 1993, 12:2257-2271. [published erratum appears in Stat Med 1994 Apr 30;13(8):871].
17. Campbell MJ: Statistics at Square Two: Understanding Modern Statistical Applications in Medicine London: British Medical Journal; 2001.
18. Shepstone L: Re-conceptualising and Generalising the Absolute Risk Difference: A unification of Effect Sizes, Odds Ratios and Number-Needed-to-Treat. Journal of Epidemiology & Community Health 2001, 55((Suppl 1) 1a):A7.
19. Collings BJ, Hamilton MA: Estimating the Power of the Two-Sample Wilcoxon Test for Location Shift. Biometrics 1998, 44:847-860.
20. Walters SJ, Brazier JE: Sample Sizes for the SF-6D Preference Based Measure of Health from the SF-36: A Comparison of Two Methods. Health Services & Outcomes Research Methodology 2003, 4:35-47.
21. Simon JL: Resampling Stats: Users Guide. v5.02 Arlington: Resampling Stats Inc; 2000.
22. Ware JE Jr, Snow KK, Kosinski M, Gandek B: SF-36 Health Survey Manual and Interpretation Guide Boston, MA The Health Institute, New England Medical Centre; 1993.
23. Elashoff JD: Query Advisor Version 3.0 User's Guide Los Angeles Statistical Solutions; 1999.
24. Sullivan lM, D'Agostino RB: Robustness and power of analysis of covariance applied to data distorted from Normality by floor effects. Statistics in Medicine 1996, 15:477-496.
25. Heeren T, D'Agostino RB: Robustness of the two independent samples t-test when applied to ordinal scaled data. Statistics in Medicine 1987, 6:79-90.
26. Sullivan lM, D'Agostino RB: Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials. Statistics in Medicine 2003, 22:1317-1334.
27. Julious SA, George S, Machin D, Stephens RJ: Sample sizes for randomized trials measuring quality of life in cancer patients. Quality of Life Research 1997, 6:109-117.
28. Thompson SG, Barber JA: How should cost data in pragmatic randomised trials be analysed? British Medical Journal 2000, 320:1197-1200.
29. Hogg RV, Tanis EA: Probability and Statistical Inference 3rd edition. New York: McMillan; 1988.
30. Troendle JF: Approximating the Power of Wilcoxon's Rank-Sum Test Against Shift Alternatives. Statistics in Medicine 1999, 18:2763-2773.
31. Lesaffre E, Scheys I, Frohlich J, Bluhmki E: Calculation of power and sample size with bounded outcome scores. Statistics in Medicine 1993, 12:1063-1078.
32. Tsodikov A, Hasenclever D, Loeffler M: Regression with Bounded Outcome Score: Evaluation of Power by Bootstrap and Simulation in a Chronic Myelogenous Leukaemia Clinical Trial. Statistics in Medicine 1998, 17:1909-1922.
33. White IR, Thomson SG: Choice of test for comparing two groups, with particular application to skewed outcomes. Statistics in Medicine 2003, 22:1205-1215.
34. Fairclough DL: Design and Analysis of Quality of Life Studies in Clinical Trials New York: Chapman & Hall; 2002.
35. Cella D, Bullinger M, Scott C, Barofsky I, and the Clinical Significance Consensus Meeting Group: Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clinic Proceedings 2002, 77(4):384-392.
36. Williamson P, Hutton JL, Bliss J, Blunt J, Campbell MJ, Nicholson R: Statistical review by research ethics committees. J Roy Statist Soc A 2000, 163:5-13.